Merck & Co. Inc. (MRK)

$ 78.80
   
  • Change Today:
    $1.18
  • 52 Week High: $132.96
  • 52 Week Low: $73.47
  • Currency: US Dollars
  • Shares Issued: 2,527.64m
  • Volume: 5,003,117
  • Market Cap: $199,173m
  • RiskGrade: 92
  • Beta: 0.32

FDA gives AstraZeneca extension on cancer drug application

By Frank Prenesti

Date: Thursday 15 Dec 2022

LONDON (ShareCast) - (Sharecast News) - The US Food and Drug Administration has given AstraZeneca and MSD a three month extension to review a new drug application for its prostate cancer treatment Lynparza.
Both companies said they would continue to work with the FDA to facilitate the completion of the agency's review.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Merck Market Data

Currency US Dollars
Share Price $ 78.80
Change Today $ 1.18
% Change 1.52 %
52 Week High $132.96
52 Week Low $73.47
Volume 5,003,117
Shares Issued 2,527.64m
Market Cap $199,173m
Beta 0.32
RiskGrade 92

What The Brokers Say

Strong Buy 8
Buy 7
Neutral 11
Sell 0
Strong Sell 0
Total 26
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 06-Jun-2025

Time Volume / Share Price
14:55 625 @ $78.80
14:55 199 @ $78.80
14:55 100 @ $78.79
14:55 100 @ $78.80
14:55 138 @ $78.80

Top of Page